These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 14527861)

  • 21. The influence of thresholds on the risk assessment of carcinogens in food.
    Pratt I; Barlow S; Kleiner J; Larsen JC
    Mutat Res; 2009 Aug; 678(2):113-7. PubMed ID: 19442758
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [A regulatory view on the article: Risk evaluation of carcinogens and their threshold levels, part I-III].
    Dieter HH; Konietzka R
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2006 Sep; 49(9):921-5. PubMed ID: 16953360
    [No Abstract]   [Full Text] [Related]  

  • 23. Risk assessment for carcinogenesis promoting agents: need for a weight of all the evidence approach.
    Clayson DB
    Prog Clin Biol Res; 1995; 391():359-67. PubMed ID: 8532728
    [No Abstract]   [Full Text] [Related]  

  • 24. [What is the understanding of the scientific basis and the regulatory toxicology associated with the term "not appreciable " in the risk evaluation of carcinogens].
    Dieter HH; Konietzka R; Neumann HG
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2007 Aug; 50(8):1084-5. PubMed ID: 17676413
    [No Abstract]   [Full Text] [Related]  

  • 25. Causes and risk factors for childhood cancer.
    Pisani P; Parodi S; Magnani C
    Epidemiol Prev; 2013; 37(1 Suppl 1):234-54. PubMed ID: 23585447
    [No Abstract]   [Full Text] [Related]  

  • 26. Carcinogen risk assessment guidelines and children.
    Buffler PA; Kyle AD
    Environ Health Perspect; 1999 Jun; 107(6):A286-8. PubMed ID: 10339455
    [No Abstract]   [Full Text] [Related]  

  • 27. [Risk evaluation of carcinogens and their threshold levels, part III].
    Neumann HG
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2006 Sep; 49(9):911-20. PubMed ID: 16937321
    [No Abstract]   [Full Text] [Related]  

  • 28. Health promotion strategies to encourage physical activity in infants, toddlers, and preschoolers.
    Gunner KB; Atkinson PM; Nichols J; Eissa MA
    J Pediatr Health Care; 2005; 19(4):253-8. PubMed ID: 16010266
    [No Abstract]   [Full Text] [Related]  

  • 29. Fetal exposure to dietary carcinogens and risk of childhood cancer: what the NewGeneris project tells us.
    Kleinjans J; Botsivali M; Kogevinas M; Merlo DF;
    BMJ; 2015 Aug; 351():h4501. PubMed ID: 26320143
    [No Abstract]   [Full Text] [Related]  

  • 30. Gender-related differences in response to mutagens and carcinogens.
    Kirsch-Volders M; Bonassi S; Herceg Z; Hirvonen A; Möller L; Phillips DH
    Mutagenesis; 2010 May; 25(3):213-21. PubMed ID: 20194421
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Toxicology and epidemiology of 1,3-butadiene.
    Himmelstein MW; Acquavella JF; Recio L; Medinsky MA; Bond JA
    Crit Rev Toxicol; 1997 Jan; 27(1):1-108. PubMed ID: 9115622
    [No Abstract]   [Full Text] [Related]  

  • 32. The relationship between carcinogenic potency and maximum tolerated dose is similar for mutagens and nonmutagens.
    Goodman G; Shlyakhter A; Wilson R
    Prog Clin Biol Res; 1991; 369():501-16. PubMed ID: 1946542
    [No Abstract]   [Full Text] [Related]  

  • 33. Identifying Potential Breast Carcinogens: A New Approach.
    Nicole W
    Environ Health Perspect; 2015 Dec; 123(12):A305. PubMed ID: 26623998
    [No Abstract]   [Full Text] [Related]  

  • 34. Towards a harmonized approach for risk assessment of genotoxic carcinogens in the European Union.
    Crebelli R
    Ann Ist Super Sanita; 2006; 42(2):127-31. PubMed ID: 17033132
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Conquering those growing pains.
    Andrews M; Baldauf S; Canada J; Courtland R; Querna B; Shute N; Streisand B
    US News World Rep; 2006 Sep; 141(8):66-8, 71-2, 74. PubMed ID: 16981413
    [No Abstract]   [Full Text] [Related]  

  • 36. IPCS harmonization of methods for the prediction and quantification of human carcinogenic/mutagenic hazard, and for indicating the probable mechanism of action of carcinogens.
    Ashby J; Waters MD; Preston J; Adler ID; Douglas GR; Fielder R; Shelby MD; Anderson D; Sofuni T; Gopalan HN; Becking G; Sonich-Mullin C
    Mutat Res; 1996 Jun; 352(1-2):153-7. PubMed ID: 8676904
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Risk assessment of dietary exposures to compounds that are genotoxic and carcinogenic--an overview.
    Dybing E; O'Brien J; Renwick AG; Sanner T
    Toxicol Lett; 2008 Aug; 180(2):110-7. PubMed ID: 18584977
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Childhood leukemia. Bad air linked to increased risk.
    Hood E
    Environ Health Perspect; 2003 Apr; 111(4):A232-3. PubMed ID: 12718315
    [No Abstract]   [Full Text] [Related]  

  • 39. DNA repair in relation to biological monitoring of exposure to mutagens and carcinogens.
    Laval F; Huet J
    IARC Sci Publ; 1984; (59):371-85. PubMed ID: 6545289
    [No Abstract]   [Full Text] [Related]  

  • 40. Children and increased susceptibility to environmental carcinogens: evidence or empathy?
    Wild CP; Kleinjans J
    Cancer Epidemiol Biomarkers Prev; 2003 Dec; 12(12):1389-94. PubMed ID: 14693727
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.